Find a Practitioner near you
Please fill in the form below to get more information or a referral to one of our Doctors close to you
Stage 3 CKD, Hypertension, Diabetes, and CHF Treatment
A 60-year-old male, Joel M reached out to Wei Kidney Institute in November 2018 looking into holistic options to help reverse his kidney disease and restore his GFR. Aside from CKD the patient also had HTN, diabetes, CHF, atrial fibrillation, ED, with a history of seizures, stroke, ankle ulcers, and GERD. The patient consulted with Dr. Lumpkin and completed the patient profile form. His main complaints were the CKD, neuropathy pain, and CHF. The patient was on several different medications including metoprolol, metformin, and warfarin to name a few.
In January 2019, he started on Wei Labs products Xcel, LC Balancer, KS, CV, and Breez, as well as with making dietary modifications to eat healthier. Xcel, LC Balancer, and KS were to address the kidney structure and function. Breez was indicated for his HTN and the CV for his heart condition.
LABS AT ONSET 10/22/18: GFR 41, Creatinine 1.79, and BUN 52.
Two weeks on the products the patient was feeling a lot better, had more energy, and his friends/family commented that he looked healthier overall. His neuropathy pain was moderating and not as strong as it was previous to starting the products. He continued to have some swelling but the discoloration in his legs had improved. His blood glucose had been well controlled averaging around 120. At the end of February, he reordered his second month of product.
At the end of month two on the products, he had an outpatient angiogram that went really well. He was expecting to have a stent placed per his doctor’s recommendation but he did not end up needing it. The ankle edema persisted, his neuropathy was bearable but still present, he noticed a decrease in his urgency and frequency, his blood pressure and blood glucose were within a normal range. He continued on just the Xcel, LCB, and KS.
At the end of month three, the edema in his ankles had gone down quite a bit and the sock line on his ankle was no longer there. He did notice his neuropathy pain creeping back up. His systolic blood pressure remains slightly elevated at times. In mid-May, the patient had an echocardiogram that showed his AFib was well controlled and everything with his heart looked good functioning at 50-60%. The patient decided to discontinue products at this time due to financials. Three months later and results were still sustained. He is working up to continue with the CHF protocol.
LAB RESULTS AUGUST 2019: GFR 71, Creatinine 1.12, BUN 24.
In January 2019, he started on Wei Labs products Xcel, LC Balancer, KS, CV, and Breez, as well as with making dietary modifications to eat healthier. Xcel, LC Balancer, and KS were to address the kidney structure and function. Breez was indicated for his HTN and the CV for his heart condition.
LABS AT ONSET 10/22/18: GFR 41, Creatinine 1.79, and BUN 52.
Two weeks on the products the patient was feeling a lot better, had more energy, and his friends/family commented that he looked healthier overall. His neuropathy pain was moderating and not as strong as it was previous to starting the products. He continued to have some swelling but the discoloration in his legs had improved. His blood glucose had been well controlled averaging around 120. At the end of February, he reordered his second month of product.
At the end of month two on the products, he had an outpatient angiogram that went really well. He was expecting to have a stent placed per his doctor’s recommendation but he did not end up needing it. The ankle edema persisted, his neuropathy was bearable but still present, he noticed a decrease in his urgency and frequency, his blood pressure and blood glucose were within a normal range. He continued on just the Xcel, LCB, and KS.
At the end of month three, the edema in his ankles had gone down quite a bit and the sock line on his ankle was no longer there. He did notice his neuropathy pain creeping back up. His systolic blood pressure remains slightly elevated at times. In mid-May, the patient had an echocardiogram that showed his AFib was well controlled and everything with his heart looked good functioning at 50-60%. The patient decided to discontinue products at this time due to financials. Three months later and results were still sustained. He is working up to continue with the CHF protocol.
LAB RESULTS AUGUST 2019: GFR 71, Creatinine 1.12, BUN 24.
| November 2018 | January 2019 | May 2019 | August 2019 | |
|---|---|---|---|---|
| GFR | 41 | 59 | 51 | 71 |
| Creatinine | 1.79 | 1.30 | 1.47 | 1.12 |
| BUN | 52 | 58 | 37 | 24 |
| Sodium | 141 | 140 | 131 | 140 |
| Potassium | 4.7 | 5.0 | 4.4 | 5.0 |
| Chloride | 106 | 104 | 102 | |
| Calcium | 8.6 | 8.4 | 8.8 | 8.8 |
| Albumin | 3.2 | 3.2 | 3.9 | 3.9 |
| Glucose | 107 | 105 | 128 | 105 |
| CO2 | 25 | 26 | 26 | 30 |
| Protein | 5.8 | 5.3 | 6.4 | 5.5 |
| Albumin | 3.2 | 2.9 | 2.8 | |
| Globulin | 2.6 | 2.5 | 3.5 | 2.7 |
| Bilirubin | 0.5 | 0.5 | 0.4 | |
| Alkaline Phosphate | 135 | 173 | 123 | 154 |
| AST | 20 | 28 | 23 | 18 |
| ALT | 17 | 29 | 20 | 14 |
You may be interested in the discussion group of